beta-glucan yeast WGP
Selected indexed studies
- Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. (Expert Opin Biol Ther, 2005) [PMID:15934844]
- Yeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer. (Clin Exp Immunol, 2023) [PMID:37455659]
- Recognition of yeast β-glucan particles triggers immunometabolic signaling required for trained immunity. (iScience, 2024) [PMID:38361630]
_Worker-drafted node — pending editorial review._
Connections
beta-glucan yeast WGP helps
beta-glucan yeast WGP protects against
Sources
- Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. (2005) pubmed
- Yeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer. (2023) pubmed
- Recognition of yeast β-glucan particles triggers immunometabolic signaling required for trained immunity. (2024) pubmed
- Orally administered yeast-derived β-glucan alleviates mast cell-dependent airway hyperresponsiveness and inflammation in a murine model of asthma. (2024) pubmed
- Baker's yeast β-glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk? (2013) pubmed
- Toxicological assessment of a particulate yeast (1,3/1,6)-beta-D-glucan in rats. (2007) pubmed
- Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer. (2016) pubmed
- Anthrax-protective effects of yeast beta 1,3 glucans. (2003) pubmed
- Beta-Glucan from S. cerevisiae Protected AOM-Induced Colon Cancer in cGAS-Deficient Mice Partly through Dectin-1-Manipulated Macrophage Cell Energy. (2022) pubmed
- β-Glucan enhances cytotoxic T lymphocyte responses by activation of human monocyte-derived dendritic cells via the PI3K/AKT pathway. (2015) pubmed